What is the recommended evaluation and management for an incidental empty sella turcica, including endocrine screening and treatment of possible intracranial hypertension?

Empty Sella Turcica: Evaluation and Management

Immediate Clinical Assessment

All patients with incidentally discovered empty or partially empty sella require comprehensive hormonal screening regardless of symptoms, as approximately 30-40% demonstrate hypopituitarism on testing, with individual axis involvement reaching up to 50%. 1, 2

The key clinical features that distinguish incidental findings from those requiring urgent intervention include:

• Visual changes (diplopia, field defects, acuity loss) suggesting optic chiasm compression or papilledema 1
• Signs of hormonal deficiency including fatigue, cold intolerance, sexual dysfunction, or features of adrenal crisis 1, 2
• Headache with features of increased intracranial pressure (worse with Valsalva, morning predominance) combined with papilledema 3, 1
• CSF rhinorrhea indicating a dural defect 1

Partially empty sella is a typical neuroimaging feature of raised intracranial pressure and may indicate underlying idiopathic intracranial hypertension (IIH), particularly when combined with headache and papilledema. 3, 1

Mandatory Hormonal Screening Panel

Order the following baseline morning fasting tests for all patients:

• Thyroid axis: TSH and free T4 (deficiency seen in 8-81% of cases) 4
• Adrenal axis: Morning cortisol and ACTH (deficiency in 17-62%) 4
• Gonadal axis: Testosterone (males), estradiol (females), FSH, and LH (deficiency in 36-96%) 4
• Growth hormone axis: IGF-1 (most commonly affected, 61-100% involvement) 4
• Prolactin: Routine measurement (elevated in ~28% of cases) 4, 2
• Electrolytes: Sodium and osmolality to screen for diabetes insipidus or SIADH 4

The growth hormone axis is the most frequently affected, followed by gonadal, adrenal, and thyroid axes in descending order. 4 Panhypopituitarism occurs in 6-29% of patients. 4

Dynamic Testing When Indicated

If baseline morning cortisol is equivocal (3-15 µg/dL), perform a 1 mcg cosyntropin stimulation test to confirm or exclude adrenal insufficiency. 4 This must be completed before initiating any glucocorticoid therapy to avoid false-negative results. 4

Patients with ≥3 confirmed pituitary hormone deficiencies are highly likely to have GH deficiency and may not require additional dynamic GH stimulation testing. 4

Imaging Recommendations

MRI with high-resolution pituitary protocols is the definitive imaging study and can reliably demonstrate empty sella without mandatory IV contrast. 3, 1, 4 If MRI already confirms partially empty sella without other concerning features (mass lesions, optic chiasm compression), no additional urgent imaging is needed. 1, 2

CT provides limited utility for detecting pituitary pathology and is insensitive compared to MRI. 1

Evaluation for Idiopathic Intracranial Hypertension

When empty sella is discovered in a patient with headache, do not attribute the headache directly to the empty sella itself, as it is usually an incidental finding unrelated to headache symptoms. 1, 2 However, do not overlook IIH as a distinct clinical entity requiring specific management. 1

Consider IIH when the following features are present:

• Younger age (mean ~36 years vs ~54 years for incidental empty sella) 5
• Headache (present in 93% of IIH patients) 5
• Visual complaints (present in 66% of IIH) 5
• Increased scalp thickness (>9 mm) or neck soft tissue thickness (>19 mm) on imaging 5
• Orbital findings suggestive of raised ICP (optic nerve tortuosity, enlarged optic nerve sheath, flattened posterior globe, bilateral transverse sinus stenosis) 3, 5

If IIH is suspected, mandatory assessment of papilledema with formal ophthalmologic examination and lumbar puncture with opening pressure measurement are required. 3

Specialist Referrals

Endocrinology referral is indicated if any hormonal abnormalities are detected on screening or if symptoms suggest pituitary dysfunction. 1, 2 Early consultation assists with interpretation of equivocal results, initiation of hormone replacement, and patient education on emergency management. 4

Ophthalmology referral is indicated if visual symptoms are present, concerns about increased intracranial pressure exist, or optic chiasm compression is noted on imaging. 1, 2

Treatment Approach

For Hormonal Deficiencies

Critical pitfall: If both adrenal insufficiency and hypothyroidism are present, always start glucocorticoid replacement before thyroid hormone replacement to avoid precipitating an adrenal crisis. 4

Patients with confirmed adrenal insufficiency require education on stress-dosing, emergency injectable steroids, and should obtain a medical-alert bracelet. 4

For central hypothyroidism, free T4 (not TSH) should guide levothyroxine dosing, targeting the upper half of the reference range. 4

For Associated IIH

Weight loss is the primary treatment for IIH-associated empty sella, with referral to weight management programs. 3, 1 Surgical CSF diversion (ventriculoperitoneal or lumboperitoneal shunt) is reserved for imminent risk of visual loss with evidence of declining visual function. 3

Ventriculoperitoneal shunt is preferred over lumboperitoneal shunt due to lower reported revision rates per patient. 3 Adjustable valves with antigravity or antisiphon devices should be considered to reduce risk of low-pressure headaches. 3

Critical Pitfalls to Avoid

• Do not skip hormonal screening in asymptomatic patients—up to 30-40% have occult hypopituitarism 1, 2
• Do not order unnecessary urgent tests that won't change immediate management in asymptomatic patients with confirmed empty sella on MRI 1
• Do not miss IIH in patients presenting with headache and empty sella—evaluate for papilledema and other features of raised ICP 3, 1
• Do not start thyroid replacement before confirming adequate cortisol in patients with multiple deficiencies 4
• Do not perform dynamic testing after starting steroids—this invalidates results 4